Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

UK set on resolving standoff with big pharma, science minister says

Patrick Vallance says relations must improve and NHS has to reverse decline in drugs investment

The Guardian - UK

UK ‘difficult’ operating environment says Merck boss after £1bn London site axed

Last week, Merck’s business in the UK and Europe, MSD, said it will move its life sciences operation to the US, impacting around 125 British jobs.

Evening Standard

Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain

The NHS needs cheap drugs, and our economy needs a thriving pharma industry. The president threatens both – no wonder Labour is grovelling to him, says Guardian columnist Polly Toynbee

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Big pharma firms have paused nearly £2bn in UK investments this year

Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

The Guardian - UK

Pharmacy leaders issue warning over ‘dangerous’ medicine delays

One pharmacist reported their patients waiting more than a week for a medication for bipolar and schizophrenia

The Independent UK

The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise

Editorial: The industry’s retreat from the UK reflects a deeper shift about how Beijing is rewriting the rules of innovation

The Guardian - UK

Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout

Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site

The investment had been set to create 1,000 jobs

The Independent UK

AstraZeneca pauses £200m investment in Cambridge research site

Decision means none of drugmaker’s much-trumpeted £650m UK investment package is currently proceeding

The Guardian - UK

Exclusive: Lutnick says Trump will force drugmakers to lower prices

Trump's efforts include reshaping drug prices through threats and public shaming.

Axios

Britain is ‘a terrible place’ to sell medicines, says drug firm executive

Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatments

The Guardian - UK

UK must heed Sir John Bell’s big pharma investment warning

Instead of making silly statements the government needs to look at why Merck has scrapped its £1bn research centre

The Guardian - UK

AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day

AbbVie stock broke out Thursday after the pharma announced it had entered a deal that will stave off generic Rinvoq until April 2037.

Investors Business Daily

Pharma giant ditches £1bn London research hub and says UK ‘is not internationally competitive’

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Big pharma will stop investing in UK, top scientist warns after Merck’s £1bn exit

Comments by former professor of medicine at Oxford follow scrapping of planned London research centre

Evening Standard

Merck scraps £1bn London expansion as report warns UK drugs sector ‘losing out’

UK pharmaceutical sector ‘risks losing investment to other countries’.

Investors Business Daily

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order

Biotech stocks Zai Labs and BeOne Medicines plummeted Wednesday on reports President Donald Trump will issue an executive order to reduce U.S. access to drugs developed in China.

The Guardian - UK

US drugmaker Merck scraps £1bn London research centre and cuts 125 science jobs

New blow to UK’s key life science sector as industry body says country is losing ground on investment and research

Get all your
news in one place.

100’s of premium titles.
One news app.

The Texas Tribune

Gov. Greg Abbott orders minors banned from THC products

Lt. Gov. Dan Patrick on Friday called Abbott’s decision a pathway to full legalization of cannabis, including marijuana which is still federally illegal. Hemp-derived THC is legal.

The Independent UK

Weight loss drugmaker to slash 9,000 jobs in £926 million cost cut

Novo Nordisk was at one point last year Europe's most valuable listed company

Investors Business Daily

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?

It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.

AAP

'Super lab': man denied bail after huge meth haul

A man has been accused of trying to flee overseas when police allegedly uncovered a drug "super lab" they claim could have produced $500 million worth of meth.

Latin Times

Police Raid Suizo Argentina and Disability Agency in Explosive Graft Probe Tied to Milei's Sister

Argentine President Javier Milei's sister, Karina Milei, is accused of taking a 3% cut in a Suizo Argentina pharmaceutical deal with the National Disability Agency. Police raids, leaked recordings, and election-year tensions intensify the scandal.

The Guardian - AU

Singapore is worried about a rise in drug-laced vaping. What is happening, and what is the drug etomidate?

Vaping has been banned since 2018, but now authorities are seeing a rise in young people using them to take an anaesthetic agent

Investors Business Daily

FDA Approves Biogen, Eisai's Highly Anticipated Alzheimer's Treatment

Biogen and Eisai won Food and Drug Administration approval of an at-home shot version of their Alzheimer's treatment Leqembi.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.